Sugi Predict

Sugi Predict / Compounds / SCHEMBL1047520

SCHEMBL1047520

SCHEMBL1047520

CNc1ncc(-c2cc3cc[nH]c(=O)c3c(Nc3ccc(C4CCN(CCCF)CC4)cc3)n2)cn1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ZAP70 P43403 18/20 0.64
▸ JAK2 O60674 1/20 0.37
▸ SYK P43405 1/20 0.37
▸ CDK2AP2 O75956 1/20 0.37
▸ EGFR P00533 1/20 0.37
▸ ERBB2 P04626 1/20 0.37
▸ LCK P06239 1/20 0.37
▸ IGF1R P08069 1/20 0.37
▸ MET P08581 1/20 0.37
▸ CYP3A4 P08684 1/20 0.37
▸ PRKCA P17252 1/20 0.37
▸ PRKACB P22694 1/20 0.37
▸ PDE4A P27815 1/20 0.37
▸ AKT1 P31749 1/20 0.37
▸ CYP2C19 P33261 1/20 0.37
▸ KDR P35968 1/20 0.37
▸ PTK2 Q05397 1/20 0.37
▸ PRKCD Q05655 1/20 0.37
▸ PDE4B Q07343 1/20 0.37
▸ PDE4C Q08493 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1047836 0.89 ZAP70 (0.79) ZAP70
SCHEMBL15290716 0.87 ZAP70 (0.59) ZAP70JAK2SYK
SCHEMBL1069445 0.85 ZAP70 (0.58) ZAP70JAK2SYK
SCHEMBL1048552 0.84 ZAP70 (0.63) ZAP70JAK2SYK
SCHEMBL1049160 0.83 ZAP70 (0.57) ZAP70CDK2AP2EGFRERBB2LCK
SCHEMBL1158070 0.83 ZAP70 (0.64) ZAP70SYK
SCHEMBL1049243 0.82 ZAP70 (0.56) ZAP70CDK2AP2EGFRERBB2LCK
SCHEMBL1082138 0.82 ZAP70 (0.56) ZAP70SYKKDR
SCHEMBL1047577 0.82 ZAP70 (0.66) ZAP70SYK
SCHEMBL1045554 0.81 ZAP70 (0.65) ZAP70JAK2SYKIGF1RCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8546370-B2 Compounds and compositions as kinase inhibitors IRM LLC (BM) 2013-10-01 — — US claimed
US-20110003798-A1 COMPOUNDS AND COMPOSITIONS AS KINASE INHIBITORS IRM LLC (BM) 2011-01-06 — — US claimed
US-8546370-B2 Compounds and compositions as kinase inhibitors IRM LLC (BM) 2013-10-01 — — US disclosed
US-8546370-B2 Compounds and compositions as kinase inhibitors IRM LLC (BM) 2013-10-01 — — US disclosed
US-8546370-B2 Compounds and compositions as kinase inhibitors IRM LLC (BM) 2013-10-01 — — US disclosed
US-20110003798-A1 COMPOUNDS AND COMPOSITIONS AS KINASE INHIBITORS IRM LLC (BM) 2011-01-06 — — US disclosed
US-20110003798-A1 COMPOUNDS AND COMPOSITIONS AS KINASE INHIBITORS IRM LLC (BM) 2011-01-06 — — US disclosed
US-20110003798-A1 COMPOUNDS AND COMPOSITIONS AS KINASE INHIBITORS IRM LLC (BM) 2011-01-06 — — US disclosed
EP-2238137-A1 COMPOUNDS AND COMPOSITIONS AS KINASE INHIBITORS IRM LLC (BM) 2010-10-13 — — EP disclosed
WO-2009097287-A1 COMPOUNDS AND COMPOSITIONS AS KINASE INHIBITORS IRM LLC (BM) 2009-08-06 — — WO disclosed
WO-2009097287-A1 COMPOUNDS AND COMPOSITIONS AS KINASE INHIBITORS IRM LLC (BM) 2009-08-06 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110003798-A1 COMPOUNDS AND COMPOSITIONS AS KINASE INHIBITORS FYN, SYK, RET ZAP70 4/4885JAK2 63/4885SYK 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.